Search Results - "Verdone, James"

Refine Results
  1. 1
  2. 2

    Tobacco treatment in the setting of lung cancer screening by Verdone, James E, Marciniak, Ellen T, Deepak, Janaki

    Published in Current opinion in pulmonary medicine (01-01-2024)
    “…Lung cancer screening by low-dose CT is an increasingly implemented preventive medicine tool. Screening for lung cancer is incomplete without addressing…”
    Get full text
    Journal Article
  3. 3
  4. 4

    A phased strategy to differentiate human CD14+monocytes into classically and alternatively activated macrophages and dendritic cells by Zarif, Jelani C, Hernandez, James R, Verdone, James E, Campbell, Scott P, Drake, Charles G, Pienta, Kenneth J

    Published in BioTechniques (01-07-2016)
    “…There are currently several in vitro strategies to differentiate human CD14(+) monocytes isolated from peripheral blood mononuclear cells (PBMCs) into the M1…”
    Get full text
    Journal Article
  5. 5

    Technical challenges in the isolation and analysis of circulating tumor cells by van der Toom, Emma E, Verdone, James E, Gorin, Michael A, Pienta, Kenneth J

    Published in Oncotarget (20-09-2016)
    “…Increasing evidence suggests that cancer cells display dynamic molecular changes in response to systemic therapy. Circulating tumor cells (CTCs) in the…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer by Gorin, Michael A., Verdone, James E., van der Toom, Emma, Bivalacqua, Trinity J., Allaf, Mohamad E., Pienta, Kenneth J.

    Published in Nature reviews. Urology (01-02-2017)
    “…Key Points Circulating tumour cells (CTCs) have been validated as prognostic biomarkers of prostate cancer. These data have been generated with a number of…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Characterization of Urothelial Cancer Circulating Tumor Cells with a Novel Selection-Free Method by Chalfin, Heather J., Kates, Max, van der Toom, Emma E., Glavaris, Stephanie, Verdone, James E., Hahn, Noah M., Pienta, Kenneth J., Bivalacqua, Trinity J., Gorin, Michael A.

    Published in Urology (Ridgewood, N.J.) (01-05-2018)
    “…To investigate circulating tumor cells (CTCs) as biomarkers of urothelial carcinoma (UC). To date, the majority of work on this topic has utilized the…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Epithelial-mesenchymal transition in prostate cancer is associated with quantifiable changes in nuclear structure by Verdone, James E., Parsana, Princy, Veltri, Robert W., Pienta, Kenneth J.

    Published in The Prostate (01-02-2015)
    “…BACKGROUND Prostate cancer progression is concomitant with quantifiable nuclear structure and texture changes as compared to non‐cancer tissue. Malignant…”
    Get full text
    Journal Article
  12. 12

    The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion by Sharma, Anup, Mendonca, Janet, Ying, James, Kim, Hea‐Soo, Verdone, James E., Zarif, Jelani C., Carducci, Michael, Hammers, Hans, Pienta, Kenneth J., Kachhap, Sushant

    Published in Molecular oncology (01-06-2017)
    “…Experimental and clinical evidence suggests that N‐myc downregulated gene 1 (NDRG1) functions as a suppressor of prostate cancer metastasis. Elucidating…”
    Get full text
    Journal Article
  13. 13
  14. 14

    The Presence of Androgen Receptor Elements Regulates ZEB1 Expression in the Absence of Androgen Receptor by Mooney, Steven M., Parsana, Princy, Hernandez, James R., Liu, Xin, Verdone, James E., Torga, Gonzalo, Harberg, Calvin A., Pienta, Kenneth J.

    Published in Journal of cellular biochemistry (01-01-2015)
    “…Zinc finger E‐box binding homeobox 1 (ZEB1) is a transcription factor that plays a central role in the epithelial to mesenchymal transition (EMT) of cancer…”
    Get full text
    Journal Article
  15. 15

    Abstract 4109: Unbiased detection of disseminated tumor cells in murine bone marrow by Valkenburg, Kenneth C., Hernandez, James R., Amend, Sarah R., Verdone, James E., Gorin, Michael A., Pienta, Kenneth J.

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…Abstract Approximately 20-30% of prostate cancer patients develop disease recurrence and metastasis years after initial therapy. This is thought to be largely…”
    Get full text
    Journal Article
  16. 16

    Alternative CD44 splicing identifies epithelial prostate cancer cells from the mesenchymal counterparts by Hernandez, James R., Kim, John J., Verdone, James E., Liu, Xin, Torga, Gonzalo, Pienta, Kenneth J., Mooney, Steven M.

    “…An epithelial to mesenchymal transition (EMT) has been shown to be a necessary precursor to prostate cancer metastasis. Additionally, the differential…”
    Get full text
    Journal Article
  17. 17

    Nucleolin staining may aid in the identification of circulating prostate cancer cells by Chalfin, Heather J, Verdone, James E, van der Toom, Emma E, Glavaris, Stephanie, Gorin, Michael A, Pienta, Kenneth J

    Published in Clinical genitourinary cancer (01-06-2017)
    “…Abstract Introduction Circulating tumor cells (CTCs) have great potential as circulating biomarkers for solid malignancies. Currently available assays for CTC…”
    Get full text
    Journal Article
  18. 18
  19. 19

    A simple selection-free method for detecting disseminated tumor cells (DTCs) in murine bone marrow by Valkenburg, Kenneth C, Amend, Sarah R, Verdone, James E, van der Toom, Emma E, Hernandez, James R, Gorin, Michael A, Pienta, Kenneth J

    Published in Oncotarget (25-10-2016)
    “…Bone metastasis is a lethal and incurable disease. It is the result of the dissemination of cancer cells to the bone marrow. Due to the difficulty in sampling…”
    Get full text
    Journal Article
  20. 20

    A surface tension magnetophoretic device for rare cell isolation and characterization by van der Toom, Emma E., Verdone, James E., Jun, Changhan, Petrisor, Doru, Lim, Sunghwan, de la Rosette, Jean J. M. C. H., de Reijke, Theo M., Gorin, Michael A., Pienta, Kenneth J., Stoianovici, Dan

    “…The cancer community continues to search for an efficient and cost-effective technique to isolate and characterize circulating cells (CTCs) as a ‘real-time…”
    Get full text
    Journal Article